Levels of inflammatory mediators in chronic obstructive pulmonary disease patients with anemia of chronic disease: a case-control study
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Although a subset of patients with chronic obstructive pulmonary disease (COPD) display anemia, the role of elevated pro-inflammatory cytokines in COPD-related anemia of chronic disease (ACD) has not been fully investigated. AIM: To examine the levels of interleukin (IL)-1β, IL-6, IL-10, tumor necrosis factor-alpha (TNFα), interferon-gamma (IFNγ), C-reactive protein (CRP) and erythropoietin in stable COPD outpatients with and without ACD. DESIGN: A case-control design was followed. METHODS: Fifty-four patients with stable COPD were studied. Among them, 27 had ACD according to strict clinical and laboratory criteria (group of cases), while another 27 nonanemic COPD patients, carefully matched to cases for age, gender, height, lung function and smoking status represented the controls. Serum levels of IL-1β, IL-6, IL-10, TNFα, IFNγ, CRP and erythropoietin were measured in both groups. RESULTS: Patients with ACD had significantly higher levels of IL-10 [25.6 (1.9-95.2) vs. 4.1 (1.9-31.9) pg/ml, P = 0.049] and IFNγ [15.2 (2.2-106.9) vs. 2 (1.2-18.3) pg/ml, P = 0.026] and had more frequently elevated CRP than controls. Levels of IL-1β [26.2 (9.8-96.4) vs. 7.9 (2.1-28.4) pg/ml, P = 0.073], IL-6 [20.3 (2.1-125.4) vs. 6.2 (1.2-33.8) pg/ml, P = 0.688] and TNFα [30.1 (3.2-107.5) vs. 10.1 (3.2-50.4) pg/ml, P = 0.131] were also higher in cases, but the differences did not reach statistical significance. Patients with ACD also displayed significantly higher erythropoietin levels than controls [(21.9 (8.4-101.7) vs. 9.7 (6.3-21.7) mIU/ml, P = 0.010], indicating erythropoietin resistance. CONCLUSION: This study shows that in stable COPD outpatients with strictly defined ACD, levels of inflammatory mediators and erythropoietin are elevated compared to nonanemic controls.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, AI shares features with the renal anemia observed in patients with chronic kidney disease (CKD), the anemia in patients with chronic obstructive pulmonary disease (COPD), the anemia in patients with CHF without or with cardio-renal syndrome, and the anemia of the elderly [23, 27, 28].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [28]
Citations
Cites
Miller, M. R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Crapo, R., Enright, P., van der Grinten, C. P. M., Gustafsson, P., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00034805 · Cited by 15,627
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Celli, B. R., MacNee, W., Agusti, A., Anzueto, A., Berg, B., Buist, A. S., Calverley, P. M. A., Chavannes, N., Dillard, T., Fahy, B., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014304 · Cited by 4,421
Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650
Systemic manifestations and comorbidities of COPD
Barnes, P. J., & Celli, B. R. (2009) · European Respiratory Journal · doi:10.1183/09031936.00128008 · Cited by 1,820
Fedorak, R. N., Gangl, A., Elson, C. O., Rutgeerts, P., Schreiber, S., Wild, G., Hanauer, S. B., Kilian, A., Cohard, M., LeBeaut, A., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.20229 · Cited by 512
Cytometric bead array: a multiplexed assay platform with applications in various areas of biology
Morgan, E., Varro, R., Sepulveda, H., Ember, J. A., Apgar, J., Wilson, J., Lowe, L., Chen, R., Shivraj, L., Agadir, A., et al. (2004) · Clinical Immunology · doi:10.1016/j.clim.2003.11.017 · Cited by 506
Cytokine-mediated regulation of iron transport in human monocytic cells
Ludwiczek, S., Aigner, E., Theurl, I., & Weiss, G. (2003) · Blood · doi:10.1182/blood-2002-08-2459 · Cited by 420
Update on Cobalamin, Folate, and Homocysteine
Carmel, R., Green, R., Rosenblatt, D. S., & Watkins, D. (2003) · Hematology · doi:10.1182/asheducation-2003.1.62 · Cited by 391
Research works printed but not linked: 3
- Brittenham, 1981, Seminars in hematology, 18, 194
- Lech-Maranda, 2006, European cytokine network, 17, 60
- 2000, 119, 1473
Cited by
Marques, O., Weiss, G., & Muckenthaler, M. U. (2022) · Blood · doi:10.1182/blood.2021013472 · Cited by 160
Erythropoiesis: insights into pathophysiology and treatments in 2017
Zivot, A., Lipton, J. M., Narla, A., & Blanc, L. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0011-z · Cited by 163
Nairz, M., Theurl, I., Wolf, D., & Weiss, G. (2016) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-016-0505-7 · Cited by 152
Iron Deficiency Anemia—Bridging the Knowledge and Practice Gap
Shander, A., Goodnough, L. T., Javidroozi, M., Auerbach, M., Carson, J. L., Ershler, W. B., Ghiglione, M., Glaspy, J. A., & Lew, I. (2014) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2014.05.001 · Cited by 130
“Some evidence suggests anemic COPD patients may have high levels of erythropoietin indicative of some degrees of erythropoietin resistance [88], while others have observed reduced level of erythropoietin during COPD exacerbation [89,90].”
BackgroundThe “Iron”-y of Iron Overload and Iron Deficiency in Chronic Obstructive Pulmonary Disease
Cloonan, S. M., Mumby, S., Adcock, I. M., Choi, A. M. K., Chung, K. F., & Quinlan, G. J. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201702-0311pp · Cited by 106
Silverberg, D. S., Mor, R., Weu, M. T., Schwartz, D., Schwartz, I. F., & Chernin, G. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-24 · Cited by 113
“Anemia in patients with COPD is likely due to a combination of several factors [26,29,33]: (i) Elevated cytokines levels, especially Tumor Necrosis Factor alpha (TNF α) and interleukin-6 (IL-6) [1,12,17,18,34,35].”
Anemia in Chronic obstructive pulmonary disease: Prevalence, pathogenesis, and potential impact
Sarkar, M. S., Rajta, P., & Khatana, J. (2015) · Lung India · doi:10.4103/0970-2113.152626 · Cited by 101
“have similarly observed significantly higher erythropoietin levels in patients with ACD than in the controls, indicating erythropoietin resistance.[58] A blunted response to erythropoietin in COPD is also increased with the advancement of COPD.”
Boutou, A., Karrar, S., Hopkinson, N. S., & Polkey, M. I. (2012) · Respiration · doi:10.1159/000338792 · Cited by 56
Self-citationOsteoporosis in chronic obstructive pulmonary disease
Romme, E. A., Smeenk, F. W. J. M., Rutten, E. P. A., & Wouters, E. F. �. (2013) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2013.814402 · Cited by 54
O’Meara, E., Rouleau, J. L., White, M., Roy, K., Blondeau, L., Ducharme, A., Neagoe, P.-E., Sirois, M. G., Lavoie, J., Racine, N., et al. (2014) · Circulation: Heart Failure · doi:10.1161/circheartfailure.114.001100 · Cited by 49
Atopic Disease and Anemia in Korean Patients: Cross-Sectional Study with Propensity Score Analysis
Rhew, K., Brown, J. D., & Oh, J. M. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17061978 · Cited by 47
Anaemia in chronic obstructive pulmonary disease. Does it really matter?
Portillo, K., Martínez‐Rivera, C., & Manzano, J. R. (2013) · International Journal of Clinical Practice · doi:10.1111/ijcp.12125 · Cited by 46
Anemia is Associated with Bone Mineral Density in Chronic Obstructive Pulmonary Disease
Rutten, E. P. A., Franssen, F. M. E., Spruit, M. A., & Wouters, E. F. �. (2012) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2012.744390 · Cited by 38
Systematic review of anaemia and inflammatory markers in chronic obstructive pulmonary disease
Hoepers, A. T. D. C., Pizzichini, M. M. M., & Fröde, T. S. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12357 · Cited by 37
“The present results indicate that patients with stable or exacerbated COPD might present with anaemia and/or elevated inflammatory markers.(20,22,23,27,30,31,41) Therefore, it is necessary to evaluate and monitor anaemia in these patients to better control their lung disease and systemic manifestations.”
BackgroundResultInfluentialHlapčić, I., Belamarić, D., Bosnar, M., Kifer, D., Dugac, A. V., & Rumora, L. (2020) · Diagnostics · doi:10.3390/diagnostics10121029 · Cited by 43
“, alpha-1 antitrypsin deficiency), cellular and molecular levels, and its manifestations are both pulmonary and extrapulmonary [3].”
BackgroundAnemia in Chronic Obstructive Pulmonary Disease and the Potential Role of Iron Deficiency
Vasquez, A. M., & Logomarsino, J. V. (2015) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2015.1043519 · Cited by 37
Anaemia in chronic obstructive pulmonary disease: an insight into its prevalence and pathophysiology
Boutou, A., Hopkinson, N. S., & Polkey, M. I. (2014) · Clinical Science · doi:10.1042/cs20140344 · Cited by 34
Self-citationImpact of anemia on short-term survival in severe COPD exacerbations: a cohort study
Ergan, B., & Ergün, R. (2016) · International Journal of COPD · doi:10.2147/copd.s111758 · Cited by 26
“12 Anemia has also been shown as an independent predictor of recurrent hospitalizations and survival in COPD patients with chronic respiratory failure.”
InfluentialSuega, K., & Widiana, G. R. (2019) · Hematology Transfusion and Cell Therapy · doi:10.1016/j.htct.2019.03.011 · Cited by 35
Correlations of Salivary Biomarkers with Clinical Assessments in Patients with Cystic Fibrosis
Nie, S., Zhang, H., Mayer, K. M., Oppenheim, F. G., Little, F. F., Greenberg, J., Uluer, A., & Walt, D. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135237 · Cited by 21
“The observation of lower levels of IL-1β in saliva from patients chronically infected with PA, and not infected with MRSA, may reflect a deficiency in innate defense or attenuation of systemic IL-1β among patients chronically infected with PA versus those with acute infection with other organisms [46].”
BackgroundEffect of gene environment interactions on lung function and cardiovascular disease in COPD
Hackett, Stefanowicz, Aminuddin, A., Sin, D. D., Connett, Anthonisen, N. R., Paré, & Sandford (2011) · International Journal of COPD · doi:10.2147/copd.s18279 · Cited by 23
Bronchoabsorption; a novel bronchoscopic technique to improve biomarker sampling of the airway
Leaker, B. R., Nicholson, G., Ali, F., Daudi, N., O’Connor, B., & Barnes, P. J. (2015) · Respiratory Research · doi:10.1186/s12931-015-0268-5 · Cited by 19
“Table 3 The range of each analyte measured in bronchoalveolar lavage (BAL) and bronchoabsorptive matrix exudate in this study compared to the data range of the analytes found in BAL samples from smokers [35–45], BAL samples from COPD subjects [35, 39, 40, 42, 46–51] and serum samples from smokers [39, 52–56] and serum…”
ResultIncreased Risk of Anemia in Patients with Asthma
Rhew, K., Choi, J., Kim, K., Choi, K. H., Lee, S.-H., & Park, H. (2023) · Clinical Epidemiology · doi:10.2147/clep.s394717 · Cited by 21
Xu, Y., Hu, T., Ding, H., & Chen, R. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2020.1816468 · Cited by 18
Xue, M., Wang, Q., Pang, B., Zhang, X., Zhang, Y., Deng, X., Zhang, Z., & Niu, W. (2023) · Biological Trace Element Research · doi:10.1007/s12011-023-03690-4 · Cited by 17
“In addition, prolonged immune activation will lead to functional iron deficiency that, over time, will develop anemia of chronic diseases [55], in association with the occurrence of lung diseases [57, 60, 61].”
BackgroundZabłocka-Słowińska, K. A., Kosacka, M., Porębska, I., Pawełczyk, K., Gołecki, M., Biernat, J., & Grajeta, H. (2017) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/65785 · Cited by 11
Nagpal, D., Singh, A., Link, J., Mehta, A. S., Kumar, A., & Budhraja, V. (2026) · Biosensors · doi:10.3390/bios16040190 · Cited by 9
Importance des comorbidités dans l’anémie de la BPCO : impact médico-économique et survie à 3 ans
Menou, A., Pain, M., Pivette, J., Chenivesse, C., Magnan, A., & Chambellan, A. (2016) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2015.12.008 · Cited by 6
Shah, J., Farooq, A., Zadran, S., Kakar, Z. H., Zarrar, M. K., & Bhatti, H. F. (2024) · Cureus · doi:10.7759/cureus.72418 · Cited by 8
“This supports earlier findings that anemia exacerbates disease outcomes, potentially worsening physical function and quality of life [15,19].”
BackgroundTrtica, M., Milenkovic, B. A., Janković, J., Dimić-Janjić, S., Dopudja-Pantic, V., & Dopsaj, V. (2023) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.14029 · Cited by 3
Akramova, E. G., & Srtuchkov, P. V. (2012) · PULMONOLOGIYA · doi:10.18093/0869-0189-2012-0-5-28-32 · Cited by 1
The development and application of an antibody microarray as a diagnostic platform for COPD
Selvarajah, S. (2013) · Nottingham ePrints (University of Nottingham) · Cited by 1
Predictors of exacerbations in COPD patients: the role of anaemia
Boutou, A., Hopkinson, N. S., & Polkey, M. I. (2013) · International Journal of Clinical Practice · doi:10.1111/ijcp.12270
Self-citationTandara, L. (2016) · Repozitorij Farmaceutsko-biokemijskog fakulteta (Sveučilišta u Zagrebu)
Boutou, A., Papathanassiou, M., & Chloros, A. (2019) · Respiratory Medicine · doi:10.1016/j.rmed.2019.05.015
Self-citationInfluence of TMPRSS6 genotype on iron status parameters in stable COPD patients
Trtica, M., Novaković, I. V., Dopsaj, V., Milenkovic, B. A., Janković, J., Dimić-Janjić, S., Dopudja-Pantic, V., Martinović, J., & Jovičić, S. Ž. (2024) · Journal of Medical Biochemistry · doi:10.5937/jomb0-52996
“Furthermore, elevated IL-6 could be responsible for hepcidin-induced reduced extracellular iron availability (3, 9, 11, 14).”
Algorashi, A., Hamza, E., Abdrabo, A., & Omer, S. (2025) · Biobacta Journal of Biochemistry and Molecular Biology · doi:10.71428/bjbmb.2025.0204
Metadata
- Authors
- Boutou, A. K., Pitsiou, G. G., Stanopoulos, I., Kontakiotis, T., Kyriazis, G., & Argyropoulou, P.
- Affiliations
- Aristotle University of Thessaloniki (GR)
- Venue
- QJM
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-02-21
- Volume
- 105
- Issue
- 7
- Pages
- 657-663
- ISSN
- 0033-5622 (ISSN-L)
- 1460-2725
- 1460-2393
- OpenAlex
- W2156953095
- Cited by
- 37
- References
- 36
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 1 · 2020: 3 · 2019: 2 · 2018: 1 · 2017: 2 · 2016: 4 · 2015: 5 · 2014: 4 · 2013: 4 · 2012: 3
- FWCI
- 4.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- QJM (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- chronic obstructive pulmonary disease, anemia of chronic disease, inflammatory mediators, inflammatory cytokines, IL-10, interferon-gamma, C-reactive protein, erythropoietin, interleukin-6, TNF-α, IL-1β, serum cytokine levels, COPD severity
- MeSH terms
- Aged, Anemia, C-Reactive Protein, Erythropoietin, Female, Humans, Male, Middle Aged, Biomarkers, Case-Control Studies, Cytokines, Inflammation Mediators, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.